NorthWest Biotherapeutics Inc (NWBO)

[Harry1969]

The reasons they stated for the delay were prefaced by the two words “such as” so not necessarily a definitive list of reasons.

My understanding is that the 10Q may cover things that occurred after Q3 if they would have a material effect on the financial statements. NWBO have disclosed such events in the past - for example financings that occurred after the balance sheet date.

What I found to be interesting was the comment regarding the accounting treatment of option awards. What would affect the accounting treatment of option awards? Just speculating, but accelerated vesting maybe? On the other hand, maybe it’s as benign as new awards were made with different performance conditions that are accounted for differently.

Hopefully we won’t have to speculate too much longer....